I am delighted to announce the publication of our chapter 'Lipodystrophy Syndromes' in the 8th edition of 'DeGroot's Endocrinology Basic Science and Clinical Practice', a prestigious and comprehensive reference that continues to serve endocrinologists and fellows worldwide.

I was so excited to give a presentation at the 19th Annual Metabolomics Conference of the Metabolomics Society #MetSoc2023, Canada, on the results of our project focusing on metabolomics and the effects of dietary patterns varying in carbohydrate and fat on specific groups of metabolites, including biomarkers of cardiometabolic disease risk.

It is an honor to be acknowledged as an outstanding Reviewer for the Annals of Internal Medicine, one of the most prestigious and influential journals in the world in the field of medicine.

I was excited to accept the invitation and become a member of the Editorial Board of the Metabolism - Clinical and Experimental Journal (Metabolism).

It was a privilege and a great honor for me to be invited to the 21st Annual Panhellenic Diabetes Conference of the Hellenic Diabetes Association (HDA) and deliver the Distinguished Lecture "The emerging role of "genomics" and "metabolomics" in metabolic diseases".

I was excited to accept the invitation and become a member of the Editorial Board of the Journal of Clinical Endocrinology & Metabolism (JCEM).

The JCEM journal of the Endocrine Society is considered a leading peer-reviewed journal for disseminating original research related to the clinical practice of endocrinology, diabetes, and metabolism.

It's a great honor to have completed the present study and a pleasure to see it published.

In this study, we aimed to investigate the metabolomic, lipid, and lipoprotein early changes induced by bariatric surgery and antiobesity/antidiabetic drugs (i.e., GLP-1 RA) in patients with obesity and/or T2D; to explore the potential shared or distinct changes observed in the metabolome, the impact of weight loss as a potential confounder and whether the different types of bariatric surgery, (i.e., vertical sleeve gastrectomy and Roux-en-Y gastric bypass), may cause different effects on the metabolome.

In this research article, the concentrations of five PGDPs (i.e., GLP-1, oxyntomodulin, glicentin, glucagon, and MPGF) were measured in 32 subjects receiving per os (PO) or intravenous (IV) glucose, lipids, or water over 6 h and in 33 subjects with normal weight, overweight or obesity who consumed a mixed meal test.

It is a great pleasure to participate in this interesting study.

In the present study, the levels of PCSK9, ANGPTL3, and FABP4 were assessed in normal subjects and subjects exhibiting HIV and HAART-induced metabolic syndrome with lipoatrophy and hypoleptinemia. Moreover, it was evaluated whether the leptin, PCSK9, ANGPTL3, and FABP4 pathways are independent of each other.

Delighted to participate in this significant field of research.

A record of 300 verified peer reviews!

A huge honor and responsibility to serve as a reviewer for several distinguished journals, including:

It is always a great honor to be a reviewer for several journals.

Serving as a reviewer for Annals of Internal Medicine, one of the most cited journals with a recent IF of 51.598, was also a wonderful surprise!

Pleased to announce that our Endocrine Reviews paper, “Novel Non-invasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy”, was chosen for the Endocrine Society Thematic Issue on Obesity 2022.

Honored to participate in the recently published method paper presenting the technical characteristics of novel ELISA assays measuring C-peptide and all six proglucagon-derived peptides (i.e., GLP-1, GLP-2, oxyntomodulin, glicentin, glucagon, major proglucagon fragment-MPGF).

The aim of our novel systematic review is to examine the effect of dietary patterns on changes in hepatic fat content, liver enzymes and metabolic syndrome components.

Delighted for our new review article, which aims to elucidate the potential underlying neuroendocrine mechanisms of the gut–brain axis and comprehensively review the observed changes of gut hormones associated with bariatric surgery.

Finally, the emerging role of post-bariatric gut microbiota modulation is also discussed.